Cargando…
Integrating In Vitro Biopharmaceutics into Physiologically Based Biopharmaceutic Model (PBBM) to Predict Food Effect of BCS IV Zwitterionic Drug (GSK3640254)
A strategy followed to integrate in vitro solubility and permeability data into a PBBM model to predict the food effect of a BCS IV zwitterionic drug (GSK3640254) observed in clinical studies is described. The PBBM model was developed, qualified and verified using clinical data of an immediate relea...
Autores principales: | Stamatopoulos, Konstantinos, Ferrini, Paola, Nguyen, Dung, Zhang, Ying, Butler, James M., Hall, Jon, Mistry, Nena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965536/ https://www.ncbi.nlm.nih.gov/pubmed/36839843 http://dx.doi.org/10.3390/pharmaceutics15020521 |
Ejemplares similares
-
Use of In Vitro Dynamic Colon Model (DCM) to Inform a Physiologically Based Biopharmaceutic Model (PBBM) to Predict the In Vivo Performance of a Modified-Release Formulation of Theophylline
por: Stamatopoulos, Konstantinos, et al.
Publicado: (2023) -
An Overview on Dietary Polyphenols and Their Biopharmaceutical Classification System (BCS)
por: Truzzi, Francesca, et al.
Publicado: (2021) -
A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP
por: Bermejo, Marival, et al.
Publicado: (2020) -
Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development
por: Wolk, Omri, et al.
Publicado: (2014) -
iBCS: 1. Principles and Framework of an Inhalation-Based
Biopharmaceutics Classification System
por: Hastedt, Jayne E., et al.
Publicado: (2022)